Skip to Main Content

+

  • • Incidence has increased with use of ultrasonography, CT, and MRI for various, nonrelated diseases of the abdomen

    • Diagnosis includes such conditions as nonfunctioning adrenocortical adenoma, functioning adenoma, pheochromocytomas with subclinical secretion of hormones, and adrenocortical carcinomas

    • Major issues to determine is whether the tumor is hormonally active or whether it is a carcinoma

++

Epidemiology

+

  • • Found in 1-4% of CT scans

    • Found in 6% of random autopsies

    • Incidence increases with age

    • Over 80% are nonfunctioning cortical adenomas

    • 5% each are preclinical Cushing syndrome, pheochromocytoma, and adrenocortical carcinoma

    • 2% are metastatic carcinoma

    • 1% are aldosteronoma

    • 25% of pheochromocytomas are found incidentally

++

Symptoms and Signs

+

  • • Asymptomatic; discovered on imaging study done for nonrelated disease process

++

Laboratory Findings

+

  • • Depends on type of tumor; nonfunctional adenoma will have no laboratory abnormalities

++

Imaging Findings

+

  • • Most pheochromocytomas are over 2 cm in diameter and characteristically bright on T2-weighted MRI

    • CT scan findings of heterogeneity or irregular borders are suspicious for malignancy

    • PET scans may be useful in detecting malignant lesions

+

  • • Simple adrenal cysts, myelolipomas, and adrenal hemorrhages can be identified by the CT characteristics alone

    • Adrenal cysts can be very large but are very rarely malignant

    • Since most tumors are nonfunctioning adenomas, the work-up should avoid unnecessary procedures and expense

    • Nonfunctioning adrenal tumors that are greater than 5 cm have a high risk of cancer (up to 33%)

    • An adrenal mass > 3 cm in a patient with a previously treated malignancy is very likely a metastasis

    • Tumors that metastasize to the adrenal gland include: lung, breast, colon, hypernephroma, malignant melanoma, uterine, and prostate

+

  • • Complete history and physical exam, with specific reference to previous malignancies, symptoms of Cushing syndrome, hypertension, virilization, or feminization

    • All patients, even those without hypertension, should have plasma metanephrines and/or 24-hour urinary fractionated catecholamines determined to evaluate for pheochromocytoma

    • All patients should have a serum cortisol, 24-hour urine collection for cortisol, and an overnight dexamethasone suppression test to assess for Cushing syndrome

    • Patients who are hypertensive should have serum potassium and plasma aldosterone and renin activity measured

    • Consider obtaining a dehydroepiandrosterone (DHEA) level (potential marker for adrenocortical carcinoma)

    • If above studies show the tumor to be nonfunctional, the size of the tumor and the patient's overall medical condition determine management

    • If metastasis is suspected and pheochromocytoma is ruled out, then CT-guided fine-needle aspiration can be useful

+

  • • Management depends on functional status and size of the tumor

    • Metastatic adrenal lesions should be treated appropriately in concert with the underlying primary cancer

++

Surgery

++

Indications

+

  • • Hormonally active tumor

    • Adrenocortical carcinoma

    • Consider for nonfunctional tumors > 4 cm

    • Solitary adrenal metastasis

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessSurgery Full Site: One-Year Subscription

Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessSurgery

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.